C60F (p.Cys60Phe) variant of KRT17 (Keratin, type I cytoskeletal 17)

C60F (p.Cys60Phe) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes population frequency data and structural context.

C60F (p.Cys60Phe) variant details